Department of Surgery, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
Brain Korea 21 Program for Biomedicine Science, Korea University College of Medicine, Korea University, Seoul, Republic of Korea.
Mol Cancer Res. 2018 Jul;16(7):1073-1076. doi: 10.1158/1541-7786.MCR-18-0055. Epub 2018 Mar 28.
Since its discovery in 2012, ferroptosis has been well characterized by the accumulation of lipid peroxides due to the failure of glutathione-dependent antioxidant defenses. It is known as an iron-dependent form of programmed cell death, which is distinct from other forms of cell death such as apoptosis and necrosis. Nonetheless, little is known about the ferroptotic agent-induced endoplasmic reticulum (ER) stress response and its role in cell death. Recent studies reveal that the ferroptotic agent-induced ER stress response plays an important role in the cross-talk between ferroptosis and other types of cell death. Ferroptotic agents induce the unfolded protein response and subsequently ER stress-mediated activation of the PERK-eIF2α-ATF4-CHOP pathway. CHOP (C/EBP homologous protein) signaling pathway-mediated p53-independent PUMA (p53 upregulated modulator of apoptosis) expression is involved in the synergistic interaction between ferroptosis and apoptosis. This review highlights the recent literature on ferroptotic and apoptotic agent interactions through the ER stress-mediated PERK-eIF2α-ATF4-CHOP-PUMA pathway and implicates combined treatment to effectively enhance tumoricidal efficacy as a novel therapeutic strategy for cancer. .
自 2012 年被发现以来,由于谷胱甘肽依赖的抗氧化防御失败导致脂质过氧化物的积累,铁死亡已得到很好的描述。它被称为一种铁依赖性的程序性细胞死亡形式,与细胞凋亡和坏死等其他形式的细胞死亡不同。然而,关于铁死亡诱导剂引起的内质网(ER)应激反应及其在细胞死亡中的作用知之甚少。最近的研究表明,铁死亡诱导剂引起的 ER 应激反应在铁死亡与其他类型的细胞死亡之间的串扰中起着重要作用。铁死亡诱导剂诱导未折叠蛋白反应,随后 ER 应激介导的 PERK-eIF2α-ATF4-CHOP 途径的激活。CHOP(C/EBP 同源蛋白)信号通路介导的 p53 非依赖性 PUMA(p53 上调凋亡调节剂)表达参与了铁死亡和细胞凋亡之间的协同相互作用。本综述强调了最近关于铁死亡和凋亡诱导剂通过 ER 应激介导的 PERK-eIF2α-ATF4-CHOP-PUMA 途径相互作用的文献,并暗示联合治疗作为一种新的癌症治疗策略可有效增强肿瘤杀伤作用。
Mol Cancer Res. 2018-3-28
Arch Toxicol. 2013-7-27
Toxicol Appl Pharmacol. 2012-9-12
Pharmaceuticals (Basel). 2025-8-21
Proc Natl Acad Sci U S A. 2016-11-1
Cell Rep. 2016-10-4
Cell Res. 2016-9
Proc Natl Acad Sci U S A. 2016-8-23
Cell Death Dis. 2016-7-21
Mol Cell Oncol. 2015-1-30
Nat Chem Biol. 2016-7